Dr. Kendrith Rowland, MD
Claim this profileCarle Cancer Center
About Kendrith Rowland, MD
Education:
- Obtained MD from the University of Illinois College of Medicine in 2015.
- Completed Residency in Internal Medicine at the same institution in 2018.
- Finished Fellowship in Hematology/Oncology at the University of Illinois College of Medicine in 2021.
Experience:
- Currently practices as a hematologist and oncologist at Carle Cancer Center.
- Specializes in internal medicine, hematology, and oncology.
Area of expertise
Breast Cancer
Kendrith Rowland, MD has run 9 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Kendrith Rowland, MD has run 6 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Carle Cancer Center
Carle Physician Group-Mattoon/Charleston
Clinical Trials Kendrith Rowland, MD is currently running
Abemaciclib + Elacestrant
for Brain Metastasis from Breast Cancer
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting
1 award
Phase 1 & 2
12 criteria
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
More about Kendrith Rowland, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Kendrith Rowland, MD has experience with
- Paclitaxel
- Nivolumab
- Carboplatin
- Cyclophosphamide
- Ipilimumab
- Ramucirumab
Breakdown of trials Kendrith Rowland, MD has run
Breast Cancer
Cancer
Breast cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kendrith Rowland, MD specialize in?
Kendrith Rowland, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Kendrith Rowland, MD currently recruiting for clinical trials?
Yes, Kendrith Rowland, MD is currently recruiting for 10 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Kendrith Rowland, MD has studied deeply?
Yes, Kendrith Rowland, MD has studied treatments such as Paclitaxel, Nivolumab, Carboplatin.
What is the best way to schedule an appointment with Kendrith Rowland, MD?
Apply for one of the trials that Kendrith Rowland, MD is conducting.
What is the office address of Kendrith Rowland, MD?
The office of Kendrith Rowland, MD is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.